Diabetes
From the Journals
Time-Restricted Eating Fails for Weight Loss and Glucose Homeostasis
Time-restricted eating offers a simplified approach to treat obesity by omitting the need for calorie counting.
Latest News
Metformin Led to Improvements in Women with Central Centrifugal Cicatricial Alopecia
Metformin led to significant clinical improvement in eight patients with CCCA, in the case series.
Latest News
A New Focus for Cushing Syndrome Screening in Obesity
Cushing Syndrome screening may be best targeted to those with phenotypes known as metabolically healthy or unhealthy obesity.
Latest News
Cell Phone Use Linked to Higher Heart Disease Risk
Study links cell phone calls, at least weekly, sleep disruption, and physicological distress to heart disease.
Latest News
How ‘Oatzempic’ Stacks up to Ozempic
TikTok-based trend claims to be effective for losing weight, but does not provide benefits like GLP-1s.
Sponsored Supplement
Integrating Incretin-Based Therapy into Type 2 Diabetes Management
Latest News
New AFib Guidelines Address Underlying Illness, Comorbidities
Class I recommendations have been issued for comorbidity, risk factor management goals, including those BP, HF, diabetes, etc.
From the Journals
How Do Plant-Based Foods Reduce Type 2 Diabetes Risk?
Higher intakes of total and individual ligands, except for lariciresinol, were associated with about 8%-27% lower T2D incidents.
Latest News
Inhaled Insulin Aids Patients With Fear of Needles
For patients who are unable to inject insulin, short-acting insulin can be inhaled for mealtime control of blood sugars.
Latest News
Men, Women, & Exercise: How Metabolism Differs
For sedentary women and men, muscle and response in burning fat and sugar are different; regular exercise can reduce the gap.
Latest News
Signal of Suicide Ideation With GLP-1 RA Semaglutide, but Experts Urge Caution
Suicidation associated with semaglutide, but researchers note analysis should not be interpreted as causation.
Latest News
First Non-Prescription Continuous Glucose Monitor Launches
The first OTC CGM for people with T2D who don’t use insulin or who have prediabetes is available for $99 a month.